Article
A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.
Nature communications - 19 Sept 2017
Yadon Adam N, Maharaj Kashmeel, Adamson John H, Lai Yi-Pin, Sacchettini James C, Ioerger Thomas R, Rubin Eric J, Pym Alexander S
Abstract excerpt
Tuberculosis chemotherapy is dependent on the use of the antibiotic pyrazinamide, which is being threatened by emerging drug resistance. Resistance is mediated through mutations in the bacterial gene pncA. Methods for testing pyrazinamide susceptibility are difficult and rarely performed, and this means that the full spectrum of pncA alleles that confer clinical resistance to pyrazinamide is unknown. Here, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
